Research report
Coeliac disease and risk of mood disorders — A general population-based cohort study

https://doi.org/10.1016/j.jad.2006.08.032Get rights and content

Abstract

Background

Earlier research has indicated a positive association between coeliac disease (CD) and some mental disorders. Studies on CD and depression have inconsistent findings and we know of no study of CD and the risk of bipolar disorder (BD).

Methods

We used Cox regression to investigate the risk of subsequent mood disorders (MD); depression and BD in 13,776 individuals with CD and 66,815 age- and sex-matched reference individuals in a general population-based cohort study in Sweden. We also studied the association between prior MD and CD through conditional logistic regression.

Results

CD was associated with an increased risk of subsequent depression (Hazard ratio (HR) = 1.8; 95% CI = 1.6–2.2; p < 0.001, based on 181 positive events in individuals with CD and 529 positive events in reference individuals). CD was not associated with subsequent BD (HR = 1.1; 95% CI = 0.7–1.7; p = 0.779, based on 22 and 99 positive events). Individuals with prior depression (OR = 2.3; 95% CI = 2.0–2.8; p < 0.001) or prior BD (OR = 1.7; 95% CI = 1.2–2.3; p = 0.001) were at increased risk of a subsequent diagnosis of CD.

Limitations

Study participants with CD and MD may have more severe disease than the average patient with these disorders since they were identified through a hospital-based register.

Conclusions

CD is positively associated with subsequent depression. The risk increase for CD in individuals with prior depression and BD may be due to screening for CD among those with MD.

Introduction

Coeliac disease (CD) affects up to 1% of all individuals in the Western world (Dube et al., 2005). The disease occurs mainly in individuals with HLA-DQ2 or DQ8 (Sollid, 2000) and is triggered by exposure to gluten (Kagnoff, 2005). CD is characterized by mucosal atrophy in the small bowel, but is also associated with extraintestinal complications (Green and Jabri, 2003), including neuropsychiatric disorders (Bushara, 2005).

Depression is a major cause of worldwide disability and is projected to become the second most important cause of disability in the Western world in the year 2020, only surpassed by ischemic heart disease (Murray and Lopez, 1997). Goldberg (Goldberg, 1970) and Hallert et al. (Hallert and Astrom, 1982a, Hallert et al., 1982b, Hallert and Derefeldt, 1982) were among the first to describe the association of CD with depression. Their papers have since been followed by a number of reports on CD and depression (Accomando et al., 2005, Addolorato et al., 2001, Addolorato et al., 1996, Carta et al., 2003, Ciacci et al., 2003, Ciacci et al., 1998, Cicarelli et al., 2003, Fera et al., 2003, Pynnonen et al., 2002, Siniscalchi et al., 2005) with varying results. Bipolar disorder (BD) is another mood disorder (MD). BD is characterized by swings in a person's mood and energy and will often lead to damaged relationship and poor performance at school or work. About 1% of the American population aged 18 years or more have, in any given year, BD (Regier et al., 1993). To our knowledge there are as yet no published studies focusing on CD and BD.

The prevalence of depression in CD varies between 6–57% (6.5% (Ciacci et al., 2003), 14% (Cicarelli et al., 2003), 17% (Siniscalchi et al., 2005), 19–24% (Fera et al., 2003), 32% (Ciacci et al., 1998), 42%(life-time risk) (Carta et al., 2002), 46–57% (Addolorato et al., 2001)), with the lowest prevalence occurring among individuals with gluten-free diet in one of the largest earlier studies (Ciacci et al., 2003). The 36 individuals with CD in the Carta et al. study were at a 2.7-fold increased risk of major depressive disorders (Carta et al., 2002) but also at an increased risk of recurrent brief depression (Carta et al., 2003). Most other studies have shown a statistically significantly positive association between CD and depression (Addolorato et al., 2001, Addolorato et al., 1996, Ciacci et al., 1998, Hallert and Astrom, 1982a, Hallert et al., 1982b, Hallert and Derefeldt, 1982, Siniscalchi et al., 2005), but not all (Accomando et al., 2005, Cicarelli et al., 2003, Fera et al., 2003, Roos et al., 2006). Despite an increased depression score in a modified version of the Zung Self-Rating Depression Scale, Fera et al found no increased risk of depression as defined by this instrument in individuals with CD (Fera et al., 2003). Neither did two recent Italian studies (Accomando et al., 2005, Cicarelli et al., 2003); or a Swedish study based on psychological general well-being scores in individuals with treated CD (Roos et al., 2006).

Several of the previous studies have been based on a limited number of patients with CD (Addolorato et al., 2001, Addolorato et al., 1996, Carta et al., 2003, Ciacci et al., 2003, Ciacci et al., 1998, Fera et al., 2003, Hallert and Astrom, 1982a, Hallert et al., 1982b, Hallert and Derefeldt, 1982, Siniscalchi et al., 2005), with only four studies including more than 100 patients with CD (Ciacci et al., 2003, Cicarelli et al., 2003, Fera et al., 2003, Siniscalchi et al., 2005) and among the three studies that used controls (Cicarelli et al., 2003, Fera et al., 2003, Siniscalchi et al., 2005), only one found an increased risk of depression in individuals with CD compared with the control population (17% vs. 0%)(Siniscalchi et al., 2005). In several of the studies, depression was identified solely through self-rating questionnaires (Accomando et al., 2005, Addolorato et al., 2001, Ciacci et al., 2003, Ciacci et al., 1998, Hallert and Astrom, 1982a, Hallert et al., 1982b, Siniscalchi et al., 2005), while the involvement of medical professionals in the diagnosis of MD is not clearly outlined in several other papers (Cicarelli et al., 2003, Fera et al., 2003). Most studies on CD and MD have been cross-sectional in nature (Accomando et al., 2005, Addolorato et al., 1996, Carta et al., 2003, Ciacci et al., 2003, Ciacci et al., 1998, Cicarelli et al., 2003, Fera et al., 2003, Goldberg, 1970, Hallert and Astrom, 1982a, Hallert et al., 1982b, Hallert and Derefeldt, 1982, Pynnonen et al., 2002, Siniscalchi et al., 2005) and when both pre- and post-CD diagnoses of psychiatric disease have been studied, temporal sequence has not been taken into account when calculating risk estimates (Addolorato et al., 2001, Carta et al., 2002). This study is designed to address some of the methodological limitations of earlier work and to examine differences in association by temporal sequence of CD and MD (depression and BD) using longitudinal data. Swedish national registers were used to conduct this research among over 13,000 individuals with CD and 66,000 individuals without the disease.

Section snippets

Participants

The Swedish National Board of Health identified all individuals with a hospital discharge diagnosis of CD between 1973 and 2003 through the Swedish National Inpatient Register (IPR). The IPR was set up in parts of Sweden in 1964, but psychiatric diagnoses became available throughout the entire country from 1973. The IPR has covered all hospital admissions in Sweden since 1987.

Every record in the IPR can be linked with patients through a unique personal identity number assigned to more than

Characteristics of participants

The median age at study entry was 2 years in both individuals with CD and those who never had a diagnosis of CD (range = 0–94 years). The first recorded diagnosis of CD was during childhood for the majority of those with CD and a higher proportion of study participants were female (Table 2). The median age at first recorded diagnosis of depression was 50 years (range: 11–87) among individuals with CD and 56 years (range: 11–94) among reference individuals. Corresponding values in BD were as

Discussion

Using longitudinal data from a national general-population based sample, we found a statistically significant positive association of CD with subsequent depression. This risk increase was also seen when we stratified for age and sex, and when we adjusted for the potential confounders DM, thyroid disease and socioeconomic status. CD was not associated with a subsequent diagnosis of BD. To our knowledge this is the first general population-based cohort study of CD and subsequent mood disorder;

Acknowledgement

JFL was supported by grants from the Örebro University Hospital and the Swedish Medical research Council while writing this article. This project was supported by The Swedish Society of Medicine, the Sven Jerring Foundation, the Juhlin Foundation, the Clas Groschinsky Foundation, the Karolinska Institute Funds, the Örebro Society of Medicine, the Majblomman Foundation and the Swedish Coeliac Society.

References (50)

  • M.F. Kagnoff

    Overview and pathogenesis of celiac disease

    Gastroenterology

    (2005)
  • S.K. Lee et al.

    Duodenal histology in patients with celiac disease after treatment with a gluten-free diet

    Gastrointest. Endosc.

    (2003)
  • C.J. Murray et al.

    Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

    Lancet

    (1997)
  • P.A. Pynnonen et al.

    Untreated celiac disease and development of mental disorders in children and adolescents

    Psychosomatics

    (2002)
  • S. Roos et al.

    Psychological well-being of adult coeliac patients treated for 10 years

    Dig. Liver Dis.

    (2006)
  • S. Saibeni et al.

    Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics

    Clin. Gastroenterol. Hepatol.

    (2005)
  • G. Addolorato et al.

    Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality “trait” or a reactive illness?

    Hepatogastroenterology

    (1996)
  • G. Addolorato et al.

    Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study

    Scand. J. Gastroenterol.

    (2001)
  • G. Addolorato et al.

    Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders

    Aliment. Pharmacol. Ther.

    (2004)
  • C.J. Bell et al.

    Acute tryptophan depletion. Part II: clinical effects and implications

    Aust. N. Z. J. Psychiatry

    (2005)
  • I. Bjelland et al.

    Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study

    Arch. Gen. Psychiatry

    (2003)
  • S.L. Brown

    Variations in utilization and cost of inpatient psychiatric services among adults in Maryland

    Psychiatr. Serv.

    (2001)
  • M.W. Carney

    Serum folate values in 423 psychiatric patients

    Br. Med. J.

    (1967)
  • D.S. Charney et al.

    Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life

    Arch. Gen. Psychiatry

    (2003)
  • C. Ciacci et al.

    Depressive symptoms in adult coeliac disease

    Scand. J. Gastroenterol.

    (1998)
  • Cited by (0)

    This project (04-030/1) was approved by the Research Ethics Committee of the Karolinska Institute, Stockholm, Sweden on the 18th March 2004.

    View full text